Skip to main content
. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3

Baldi 1991.

Methods RCT
Participants 71 patients with IBS
8 GI centres
Mean age 40 years
60.6% female
Interventions Spasmolytic 
 4 weeks 
 otilonium 40 mg tds
Outcomes abdominal pain
Notes 2 wk run‐in with placebo
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Double‐blind, methods not described
Incomplete outcome data (attrition bias) 
 All outcomes Low risk One drop‐out
Selective reporting (reporting bias) Low risk All expected outcomes were reported
Other bias Low risk The study appears to be free of other sources of bias